Please ensure Javascript is enabled for purposes of website accessibility

Why Align Technology, Bausch Health, Momenta Pharmaceuticals, and ShockWave Medical Stocks Soared Today

By Keith Speights – Apr 6, 2020 at 4:21PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Optimism that the worst might be over with the COVID-19 outbreak fueled investors' enthusiasm for these healthcare stocks.

What happened

Shares of several healthcare stocks soared today as the broader market jumped after the number of new COVID-19 cases in the U.S. appeared to have slowed somewhat. Align Technology (ALGN 6.62%) stock vaulted 14.6% higher. Shares of Bausch Health Companies (BHC 7.26%) rose 9.8%. Momenta Pharmaceuticals (MNTA) stock climbed 15.6% higher. And shares of ShockWave Medical (SWAV 2.84%) were up 10.6% at the close of trading today.

So what

Johns Hopkins reported that the number of new COVID-19 cases in the U.S. on Sunday totaled 28,222. That was down from 33,264 on Saturday and 32,133 on Friday. This decline caused the five-day moving average of new COVID-19 cases to fall for the first time since the coronavirus pandemic started.

Businessman holding up a red line that was going down but is now trending up.

Image source: Getty Images.

Any signs that the worst might be over for the COVID-19 outbreak that has shut down much of the global economy is good news. For Align Technology, it could mean that the company could soon see a rebound in sales for its clear orthodontic aligners as patients are able to return to visiting dental professionals. For Bausch Health, a return to normal could boost sales of its eye-care and other products. 

Momenta Pharmaceuticals could be able to resume enrolling in some of its planned clinal studies if individuals could soon be able to leave their homes without fear of being infected by the novel coronavirus. ShockWave Medical's intravascular lithotripsy (IVL) device sales could also benefit once hospitals can go back to business as usual.

However, investors shouldn't pin all of their hopes on one day of diminished COVID-19 numbers. The situation could get worse before it gets better. Don't be surprised if today's gains are quickly erased.

Now what

The main thing for investors to look forward to with all four of these healthcare stocks is their long-term prospects.

As a clinical-stage drugmaker, Momenta faces the highest level of risk but also the potential for significant gains if its pipeline candidates are successful. Bausch Health continues to deal with sinking sales for some of its products that have lost exclusivity. On the other hand, the company has solid eye-care and surgical businesses and has new pharmaceutical products on the market.

There's a pretty good argument that Align Technology and ShockWave Medical have the strongest growth prospects. Align's clear orthodontic aligners remain popular, and the company continues to invest in marketing to build patient awareness of its products. ShockWave Medical's IVL devices could have a $6 billion addressable market. Both Align and ShockWave should bounce back nicely when the COVID-19 crisis has passed.

Keith Speights owns shares of Align Technology. The Motley Fool owns shares of and recommends Align Technology, Bausch Health Companies, and ShockWave Medical. The Motley Fool recommends Momenta Pharmaceuticals. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bausch Health Companies Inc. Stock Quote
Bausch Health Companies Inc.
$7.54 (7.26%) $0.51
Align Technology, Inc. Stock Quote
Align Technology, Inc.
$229.91 (6.62%) $14.27
Momenta Pharmaceuticals, Inc. Stock Quote
Momenta Pharmaceuticals, Inc.
ShockWave Medical Stock Quote
ShockWave Medical
$286.87 (2.84%) $7.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.